EUVIMED · CrossrefJournal
Translational Lung Cancer Research
ISSN 2218-6751 · AME Publishing Company
Latest articles
Immune-preserving radiotherapy and perioperative immunotherapy in stage III NSCLC: a narrative review of current management and future directions for IIIA/IIIB NSCLC
Tertiary lymphoid structures predict the neoadjuvant chemoimmunotherapy response of stage III non-small cell lung cancer
Longevity-associated FOXO3 genotype mitigates the risk of lung cancer after smoking cessation: a prospective cohort study
Elevated serum neuron-specific enolase as an indicator of poor chemo-immunotherapy outcomes and reduced CD8-positive lymphocyte infiltration in small-cell lung cancer: a retrospective cohort study
Real-world analysis in patients with limited-stage small-cell lung cancer who received durvalumab after concurrent chemoradiotherapy
Deciphering lung cancer at high resolution: a narrative review of applications of single-cell and spatial transcriptomics sequencing
Epigenetics in lung cancer precision medicine: from bench to bedside—a narrative review
Best supportive care in stage I–III non-small cell lung cancer: survival by reason for curative treatment omission in a real-world study population
Development and validation of a machine learning model for predicting objective response to PD-1 inhibitors in lung cancer patients
Neoadjuvant befotertinib plus vorolanib in resectable stage II–IIIB EGFR-mutant NSCLC: a study protocol for the prospective, single-arm phase I/II trial
Treatment patterns and outcomes of later-line therapy in advanced non-small cell lung cancer with unknown or no actionable genomic alterations: a multicenter real-world study in China (RECAP study)
Role and clinical significance of VISTA (PD-1H) and PVR (CD155) expression in non-small cell lung carcinoma: a systematic review
Non-destructive three-dimensional structural assessment of transbronchial cryobiopsy specimens using phase-contrast X-ray CT: a proof-of-concept study
A retrospective cohort study integrating invasive mucinous adenocarcinoma into the IASLC grading system for lung adenocarcinoma
CT-derived abdominal organ volumetrics for predicting recurrence-free and disease-free survival in resected non-small cell lung cancer: a multicenter retrospective cohort study
Baseline IL-6, IL-8, IFN-ω, and perforin as prognostic biomarkers in immune checkpoint inhibitor-treated metastatic non-small cell lung cancer
Promising benefits of MET inhibition combined with EGFR/ALK tyrosine kinase inhibitor in heavily treated non-small cell lung cancer patients with EGFR-mutant/ALK rearrangement and MET overexpression: a retrospective cohort study
Multiplexed quantitative proteomics in small-cell lung cancer: stage-linked DLL3 distribution and an independent prognostic signal of thymidine phosphorylase
Strengthening the EGFR blockade for those lung cancers that need it most
The detection of MTAP loss in non-small cell lung cancer: a novel biomarker with therapeutic implications
Development and validation of machine learning diagnostic models integrating clinical, CT, and laboratory features to differentiate lung cancer from pulmonary tuberculosis in patients with solitary pulmonary nodules: a single-center retrospective study
Trophoblast cell-surface antigen 2-targeted “sacituzumab tirumotecan”: a new approach for epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small cell lung cancer
Targeted therapeutic strategies for KRAS-G12D-mutant non-small cell lung cancer: a narrative review
Predictors of prolonged hospital stay in patients with lung cancer undergoing sublobar resection
Association of symptoms at diagnosis with prognosis in patients with surgically treated stage I non-small cell lung cancer: a retrospective cohort analysis of a prospectively maintained registry
FOXA1 drives chemoresistance through activating Wnt pathway in small cell lung cancer
Intratumor immune heterogeneity across simulated core biopsy sizes in non-small cell lung cancer: an exploratory study
LPIN2 contributes to tyrosine kinase inhibitor resistance via activation of PI3K pathway
Osalmid inhibits lung adenocarcinoma progression and enhances EGFR-TKI responses: a preclinical and translational study
Current advances in extended resections for non-small cell lung cancer—a narrative review
EUVIMED